Veterinary Medicine Information website

TILMI-kel 300 mg/ml solution for injection for cattle

Not authorised
  • Tilmicosin
Download as PDF

Product identification

Medicine name:
TILMI-kel 300 mg/ml solution for injection for cattle
Active substance:
  • Tilmicosin
Target species:
  • Sheep
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Tilmicosin
    300.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        42
        day
      • Milk
        18
        day
    • Cattle
      • Meat and offal
        70
        day
      • Milk
        36
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Slovakia
Package description:
  • box containing 12 vials of 250 ml
  • box containing 12 vials of 100 ml
  • box containing 12 vials of 50 ml
  • box containing 10 vials of 250 ml
  • box containing 10 vials of 100 ml
  • box containing 10 vials of 50 ml
  • box containing 6 vials of 250 ml
  • box containing 6 vials of 100 ml
  • box containing 6 vials of 50 ml
  • box containing 1 vial of 250 ml
  • box containing 1 vial of 100 ml
  • box containing 1 vial of 50 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
  • Industrial Veterinaria S.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/037/DC/09-S
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0144/001